The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Phase 2

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Phase 2 · 24 people · 1 site in United States · Recruiting now

August 14, 2026
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

Phase 2 · 240 people · 27 sites in China · Recruiting now

August 14, 2026
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Phase 2 · 270 people · 10 sites in 2 countries · Recruiting now

August 14, 2026
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer

Phase 2 · 70 people · 6 sites in United States · Recruiting now

August 14, 2026
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Phase 2 · 366 people · 19 sites in 4 countries · Recruiting now

August 14, 2026
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 2 · randomised · 100 people · 2 sites in United States · Recruiting now

August 11, 2026
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Phase 2 · 60 people · 1 site in China · Recruiting now

August 11, 2026
Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer

Phase 2 · 148 people · 1 site in Norway · Recruiting now

August 11, 2026
A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

Phase 2 · 25 people · 1 site in China · Recruiting now

August 11, 2026
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.

Phase 2 · 502 people · 1 site in China · Recruiting now

August 11, 2026